Latest Proof Snapshot
The latest reported quarter is fiscal Q1 2026: the earnings release was dated and furnished on 29 April 2026, and the Form 10-Q for fiscal Q1 was filed the same day. Net sales were $21.861bn versus $11.643bn a year earlier, helped by Viterra scale, but reported diluted EPS fell to $0.35 from $1.48 while adjusted diluted EPS was $1.83 versus $1.81. The accounting gap matters: adjusted net income attributable to Bunge was $359m, but reported net income attributable to Bunge was only $68m after the net-income bridge added back a $250m after-tax mark-to-market timing difference and $41m of acquisition and integration costs as presented in the adjusted net-income reconciliation. Cash did not yet confirm the adjusted earnings bridge. Q1 2026 cash used in operating activities was $541m and payments for capital expenditures were $336m, so the single-quarter reported post-capex cash deficit was about $877m before dividends of $136m. Management's adjusted funds from operations was $530m, up from $392m, and full-year adjusted EPS guidance was raised to $9.00-$9.50, but management also guides to $1.5bn-$1.7bn of 2026 capex and $620m-$660m of net interest expense. The investment test is whether the higher adjusted earnings base converts into post-capex cash while total debt of $14.553bn and inventories of $15.428bn are being carried.